Long-term Tecfidera use was found to significantly reduce relapse rates and slow disability progression for MS patients in a ...

Certain health issues seen in youth with MS in the five years before diagnosis confirm a prodromal period may exist in ...

Columnist Ben Hofmeister is learning that navigating life with multiple sclerosis is a journey, rather than a quest or an adventure.

Most MS treatments don't increase the risk for miscarriage or major birth defects when used during pregnancy, an analysis ...

The team at Multiple Sclerosis News Today has brought our audience the latest news about treatments, scientific research, and clinical trials in multiple sclerosis (MS) throughout 2024. Here is a ...

People with multiple sclerosis (MS) show significant differences between actual age and vascular age, an indicator of heart and blood vessel health, even if they don’t have any cardiovascular ...

Men with MS who started on high-efficacy DMTs had fewer relapses than those who started with moderate-efficacy DMTs, a U.S.

Men with multiple sclerosis (MS) who started on high-efficacy disease-modifying therapies (DMTs) experienced significantly fewer relapses than those who started with moderate-efficacy DMTs ...